Cantor Fitzgerald initiated coverage on Nyxoah with a new price target
$NYXH
Medical/Dental Instruments
Health Care
Cantor Fitzgerald initiated coverage of Nyxoah with a rating of Overweight and set a new price target of $43.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/31/2023 | Buy | H.C. Wainwright | |
7/19/2023 | Neutral | Robert W. Baird | |
4/21/2022 | $30.00 | Outperform | Oppenheimer |
4/6/2022 | $21.00 | Peer Perform | Wolfe Research |
12/21/2021 | $47.00 | Overweight | Cantor Fitzgerald |
7/28/2021 | $43.00 | Overweight | Cantor Fitzgerald |
7/28/2021 | $40.00 | Overweight | Piper Sandler |
7/27/2021 | $43.00 | Buy | Stifel |